| Serial Number | 79324555 |
| Word Mark | B |
| Filing Date | Monday, May 24, 2021 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, November 1, 2022 |
| Registration Number | 6886644 |
| Registration Date | Tuesday, November 1, 2022 |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, August 16, 2022 |
| Description of Mark | The mark consists of the left-slanting capital letter "B" in blue and the parallelogram on the upper left corner of the "B" in green. The white background is not claimed as a feature of the mark. |
| Goods and Services | Cultures of microorganisms for medical or veterinary use; medical dressings; pharmaceutical preparations for human use for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations for human use for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; pharmaceutical preparations for human use for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations for human use, namely, anti-infectives; antifungal pharmaceutical preparations for human use; Chinese traditional medicinal herbs for human use; pharmaceutical preparations for human use for antitussive-cold; pharmaceutical preparations for human use for the prevention and treatment of cancer; pharmaceutical preparations for human use for the treatment of psychiatric diseases and disorders; pharmaceutical preparations for human use for the treatment of heart rhythm disorders; medicated throat sprays for human use; diuretic pharmaceutical preparations for human use; pharmaceutical preparations for human use for the treatment of musculo-skeletal disorders; pharmaceutical preparations for human use for the treatment of hyperlipidemia; antitussives for human use; otorhinolaryngological pharmaceutical preparations for human use; anaesthetics for human use; pharmaceutical preparations for human, namely, antidepressants; pharmaceutical preparations for human use for the treatment of eye diseases and conditions; headache treatment pharmaceutical preparations for human use; nasal spray preparations for human use; medicines for human use for the treatment of gastrointestinal diseases; medicinal preparations for the mouth and as sprays for human use; thyroid and para-thyroid hormone pharmaceutical preparations for human use; sulfonamide pharmaceutical preparations for human use; pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension for human use; pharmaceutical preparations acting on the central nervous system for human use; pharmaceutical preparations for human use for the treatment of erectile dysfunction; pharmaceutical solutions used in dialysis for human use; pharmaceutical preparations for human use for the treatment of bone diseases; antipyretic analgesics for human use; antiallergic medicines for human use; anti-diabetic pharmaceutical preparations for human use; hypnotic sedatives for human use; cardiovascular pharmaceutical preparations for medical purposes for human use; hemostatics for medical purposes for human use; antihemorrhoidal pharmaceutical preparations for human use; anti-epileptic pharmaceutical preparations for human use; cerebral hemorrhage prophylactic pharmaceutical preparations for human use; pharmaceutical preparations for human use for the treatment of immune system related diseases and disorders; pharmaceutical preparations for human use for treating hypertension; athlete's foot pharmaceutical preparations for human use; pharmaceutical preparations for human use for treating asthma; pharmaceutical preparations for human use for the treatment of hormonal disorders; medicated mouth treatment pharmaceutical preparations for human use; motion sickness medicines for human use; diarrhea medication for human use; pesticides; medicines for veterinary purposes, namely, pain relief medication; veterinary vaccines; anti-infectives products for veterinary use; bacteriological medicinal preparations for veterinary purposes; medicines for veterinary purposes, namely, for treatment of intestinal bacteria; medicines for veterinary purposes for the treatment of animals' skin diseases; medicines for veterinary purposes for the treatment of wounds; albumin dietary supplements for medical purposes; depuratives for the body; oxygen for medical purposes; nitrous oxide for medical use; radioactive substances for medical purposes |
| Indication of Colors claimed | The color(s) blue and green is/are claimed as a feature of the mark. |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, November 8, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Chengdu Brilliant Pharmaceutical Co., Ltd. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | CN |
| Party Name | Chengdu Brilliant Pharmaceutical Co., Ltd. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | CN |
| Party Name | Chengdu Brilliant Pharmaceutical Co., Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | CN |
| Event Date | Event Description |
| Tuesday, March 21, 2023 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Tuesday, February 28, 2023 | FINAL DISPOSITION NOTICE SENT TO IB |
| Monday, February 27, 2023 | FINAL DISPOSITION PROCESSED |
| Wednesday, February 1, 2023 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, November 1, 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, November 1, 2022 | REGISTERED-PRINCIPAL REGISTER |
| Monday, October 17, 2022 | ASSIGNED TO EXAMINER |
| Wednesday, August 17, 2022 | NOTIFICATION PROCESSED BY IB |
| Tuesday, August 16, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, August 16, 2022 | PUBLISHED FOR OPPOSITION |
| Wednesday, July 27, 2022 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, July 27, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, July 27, 2022 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Monday, July 11, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, July 8, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, July 7, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, July 7, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, April 4, 2022 | REFUSAL PROCESSED BY IB |
| Monday, March 14, 2022 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Monday, March 14, 2022 | REFUSAL PROCESSED BY MPU |
| Saturday, February 12, 2022 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Friday, February 11, 2022 | NON-FINAL ACTION WRITTEN |
| Friday, February 4, 2022 | ASSIGNED TO EXAMINER |
| Friday, November 12, 2021 | APPLICATION FILING RECEIPT MAILED |
| Monday, November 8, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, November 5, 2021 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
| Friday, October 29, 2021 | SN ASSIGNED FOR SECT 66A APPL FROM IB |